Condition: Hereditary Cancer Syndrome · Sponsor: University Health Network, Toronto
The goal of this study is to understand the performance of an experimental blood test that aims to detect early tumors in patients with hereditary cancer syndromes. If this new blood test is accurate, it could be used to screen patients for cancer and allow for earlier cancer detection. The study will compare cancer detection rates between those receiving the new blood test and those receiving standard care, assess if the test leads to earlier cancer diagnosis, and evaluate its impact on patient outcomes. The study will also use questionnaires and interviews to understand how patients feel about the blood test, its incorporation into routine medical care, and perceptions of the medical value of test results. This research could lead to more effective and less invasive cancer screening for high-risk individuals.
This description comes directly from the study's public registry record.
Julia Sobotka, MSc · 416-409-1387 · charm@uhn.ca
Always discuss trial participation with your own doctor first.
| BC Cancer Agency | Vancouver, British Columbia, Canada | Not Yet Recruiting |
| Eastern Health | St. John's, Newfoundland and Labrador, Canada | Not Yet Recruiting |
| IWK Health Centre | Halifax, Nova Scotia, Canada | Not Yet Recruiting |
| The Hospital for Sick Children | Toronto, Ontario, Canada | Not Yet Recruiting |
| Sinai Health System | Toronto, Ontario, Canada | Recruiting |
| University Health Network | Toronto, Ontario, Canada | Recruiting |
| Women's College Hospital | Toronto, Ontario, Canada | Not Yet Recruiting |
| Jewish General Hospital | Montreal, Quebec, Canada | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06726642